Research Article | Open Access
Ali Mohamadi Sani, Mohamad Khezri, Halime Moradnia, "Determination of Aflatoxin in Milk by ELISA Technique in Mashad (Northeast of Iran)", International Scholarly Research Notices, vol. 2012, Article ID 121926, 4 pages, 2012. https://doi.org/10.5402/2012/121926
Determination of Aflatoxin in Milk by ELISA Technique in Mashad (Northeast of Iran)
The aim of this study was to detect the amount of aflatoxin M1 (AFM1) in pasteurized milk samples in Mashad in northeast of Iran. For this purpose, 42 milk samples were collected from retail stores during fall 2011 and analyzed for AFM1 by enzyme-linked immunosorbent assay (ELISA) technique. All the analyses were done twice. Results showed presence of AFM1 in 97.6% of the examined milk samples by average concentration of 23 ± 16 ppt and contamination level ranging between 6 and 71 ppt. The concentration of AFM1 in all the samples was lower than the Iranian national standard and Food and Drug Administration limits (500 ppt), and, only in 3 (1.6%) samples, AFM1 concentration was more than the maximum tolerance limit (50 ppt) accepted by European Union and Codex Alimentarius Commission. According to our findings and previous studies, AFM1 contamination of milk is not a concern in this region, and the regional standard of AFM1 contamination in milk might be changed to lower than 100 ppt.
Mycotoxins are secondary metabolites of molds which are associated with certain disorders in animals and humans. In addition to being acutely toxic, some mycotoxins are now linked with the incidence of certain types of cancer, and it is this aspect which has evoked global concern over feed and food safety, especially for milk and milk products . Aflatoxin (AFM1) is a hepatocarcinogen found in milk of animals that have consumed feeds contaminated with aflatoxin B1 (AFB1), the main metabolite produced by fungi of the genus Aspergillus, particularly A. flavus, A. parasiticus, and A. nomius . About 0.3–6.2% of AFB1 in animal feed is transformed to AFM1 in milk . Due to serious health concerns, many countries have set maximum limits for aflatoxins, which vary from country to country . The European Community prescribes that the maximum level of AFM1 in liquid milk should not exceed 50 ppt. However, according to the US standard, the level of AFM1 in liquid milk should not be higher than 500 ppt . There have been several studies on AFM1 concentration in milk samples in different regions of the world and also in Iran, but this study was done to evaluate the occurrence of AFM1 in milk distributed in Mashad in northeast of Iran in order to evaluate the potential of changing the regional standard on AFM1 contamination of milk.
2. Materials and Methods
In this study the AFM1 content of pasteurized milk samples in retail stores in Mashad (northeast of Iran) was determined in fall 2011. Forty-two pasteurized milk samples (1000 mL milk packets, heat treated at 72–74.4Ć for 15–20′′) from different brands were collected by simple random sampling method. The samples were transported to the laboratory in an insulated container at about 4°C and analyzed upon arrival.
Most of the reagents used to detect AFM1 were contained in the RIDASCREEN test kit, which included microtiter plate coated with capture antibodies, AFM1 standard solutions used for the construction of the calibration curve (1.3 mL each 0, 5, 10, 20, 40, and 80 ppt), peroxidase-conjugated AFM1, substrate (urea peroxidase), chromogen (tetramethylbenzidine), and stop reagent contains 1N sulphuric acid. Methanol used was of analytical grade and provided by Merck.
2.2.1. AFM1 Detection
The quantitative analysis of AFM1 in pasteurized milk samples was performed by competitive ELISA (RIDASCREEN AFM1, R-Biopharm) procedure as described by R-biopharm GmbH . Prior to analysis of the samples, the ELISA method was validated to ensure data quality. Validation of ELISA was carried out by determination of recoveries and the mean variation coefficient for fresh milk spiked with different concentrations of AFM1 (5, 10, 20, 40 and 80 ppt). The results are expressed in Table 1.
Milk samples were centrifuged at 3500 g for 10 min at 10°C. The upper creamy layer was completely removed by aspirating through a Pasteur pipette and from the lower phase (defatted phase) 100 μL was directly used per well in the test. One hundred μL of the AFM1 standard solutions (100 μL/well) and test samples (100 μL/well) in duplicate were added to the wells of microtiter plate and incubated for 60 min at room temperature in the dark. After the washing steps, 100 μL of the enzyme conjugate was added and incubated for 60 min at room temperature in the dark. The washing step was repeated three times. Fifty μL of substrate and 50 μL of chromogen were added to each well and mixed thoroughly and incubated for 30 min in the dark. Following the addition of 100 μL of the stop reagent to each well, the absorbance was measured at 450nm in ELISA reader (ELX-800, Bio-Tek Instruments, USA). According to the RIDASCREEN kit guidelines, the lower detection limit is 5 ppt for milk.
2.2.2. Evaluation of AFM1
The absorbance values obtained for the standards and the samples were divided by the absorbance value of the first standard (zero standards) and multiplied by 100 (percentage maximum absorbance). Therefore, the zero standard is thus made equal to 100%, and the absorbance values are quoted in percentages. The values calculated for the standards were entered in a system of coordinates on semilogarithmic graph paper against the AFM1 concentration in ppt (Figure 1). The equation of the trendline in Figure 1 is as follows:
3. Statistical Analysis
Data were analysed using Excel 2007 and results reported as . The calibration curve and trendline equation prepared using Excel 2007.
4. Results and Discussion
The standard solutions of concentration from 5 to 80 ppt AFM1 were used to find calibration/standard curve. The results showed the linearity of the standard curve over the range studied. Figure 1 gives the calibration curve of standard solutions of AFM1 with concentrations of 5, 10, 20, 40, and 80 ppt by ELISA analysis.
Analytical results showed that the incidence of AFM1 contamination in pasteurized milk samples was low. Although 97.6% of the samples were contaminated with AFM1, the toxin concentration was lower than Iranian national standard and FDA limit (500 ppt) and only in three (1.6%) of the samples AFM1 concentration was greater than the maximum tolerance limit (50 ppt) accepted by European Union and Codex Alimentarius Commission. Table 2 shows the distribution and percentage of AFM1 contamination in pasteurized milk samples. The minimum and maximum contamination level of AFM1 was found to be 6.4 and 71.4 ppt, respectively. The AFM1 level in the analyzed samples of pasteurized milk was ppt.
| number of contaminated samples.|
%2 Percentage of AFM1 positive samples.
*71.3 ppt in the contaminated sample.
The mean AFM1 concentrations in milk in European, Latin American, and Far Eastern diets have been reported by the Joint FAO/WHO Expert Committee on Food Additives  to be 23, 22, and 360 ng/L, respectively. Thus, the observed mean AFM1 concentration in Mashad milk samples was as high as the European and Latin American and much lower than those reported for the Far Eastern diets.
On the other hand, several studies have been done to determine AFM1 contamination of milk in Iran (Table 3). The incidence of AFM1 observed in the present study was lower than the incidence of AFM1 reported by other authors [8–17], yet, in all studies, the averages of toxin concentrations are below 100 ppt. The variations may be attributed to differences in region, season, and especially analysis method.
Based on the above results, especially later studies in Mashad, the present situation is hopeful and might represent the possibility of altering standard limit of AFM1 concentration in milk in Iran. We suggest reduction of the limit as low as 100 ppt for raw milk.
Conflict of Interests
The authors declare that there is no conflict of interests.
The authors acknowledge funding support for this study by Mashad University of Medical Sciences.
- M. Castegnaro and D. McGregor, “Carcinogenic risk assessment of mycotoxins,” Revue de Medecine Veterinaire, vol. 149, no. 6, pp. 671–678, 1998.
- F. Galvano, V. Galofaro, A. Ritieni, M. Bognanno, A. De Angelis, and G. Galvano, “Survey of the occurrence of aflatoxin M1 in diary products marketed in Italy: second year of observation,” Food Additives and Contaminants, vol. 18, no. 7, pp. 644–646, 2001.
- E. E. Creppv, “Update of survey, regulation and toxic effects of mycotoxins in Europe,” Toxicology Letters, vol. 127, no. 1–3, pp. 19–28, 2002.
- J. Chen and J. Gao, “The Chinese total diet study in 1990. Part I. Chemical contaminants,” Journal of AOAC International, vol. 76, no. 6, pp. 1193–1205, 1993.
- L. Stoloff, H. P. Van Egmond, and D. L. Park, “Rationales for the establishment of limits and regulations for mycotoxins,” Food Additives and Contaminants, vol. 8, no. 2, pp. 213–222, 1991.
- R-Biopharm GmbH, “Enzyme immunoassay for the quantitative analysis of aflatoxins,” Ridascreen Aflatoxin M1 Art. R-1101, R-Biopharm GmbH, Darmstadt, Germany, 1999.
- JECFA, “Safety evaluation of certain mycotoxins in food,” in Proceedings of the 56th Meeting of the Joint FAO/WHO Expert Committee on Food Additives, vol. 47 of Food Additives Series, World Health Organization, Geneva, Switzerland, 2001.
- A. Mohamadi Sani and H. Nikpooyan, “Determination of aflatoxin M1 in milk by high-performance liquid chromatography in Mashhad (north east of Iran),” Toxicology and Industrial Health. In press.
- A. Mohamadi Sani, H. Nikpooyan, and R. Moshiri, “Aflatoxin M1 contamination and antibiotic residue in milk in Khorasan province, Iran,” Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2130–2132, 2010.
- M. Tajkarimi, F. Shojaee Aliabadi, M. Salah Nejad, H. Pursoltani, A. A. Motallebi, and H. Mahdavi, “Seasonal study of aflatoxin M1 contamination in milk in five regions in Iran,” International Journal of Food Microbiology, vol. 116, no. 3, pp. 346–349, 2007.
- A. Kamkar, “A study on the occurrence of aflatoxin M1 in raw milk produced in Sarab city of Iran,” Food Control, vol. 16, no. 7, pp. 593–599, 2005.
- S. Alborzi, B. Pourabbas, M. Rashidi, and B. Astaneh, “Aflatoxin M1 contamination in pasteurized milk in Shiraz (south of Iran),” Food Control, vol. 17, no. 7, pp. 582–584, 2006.
- M. Tajkarimi, F. Aliabadi-Sh, A. S. Nejad, H. Poursoltani, A. A. Motallebi, and H. Mahdavi, “Aflatoxin M1 contamination in winter and summer milk in 14 states in Iran,” Food Control, vol. 19, no. 11, pp. 1033–1036, 2008.
- A. A. Fallah, “Assessment of aflatoxin M1 contamination in pasteurized and UHT milk marketed in central part of Iran,” Food and Chemical Toxicology, vol. 48, no. 3, pp. 988–991, 2010.
- M. Nemati, M. A. Mehran, P. K. Hamed, and A. Masoud, “A survey on the occurrence of aflatoxin M1 in milk samples in Ardabil, Iran,” Food Control, vol. 21, no. 7, pp. 1022–1024, 2010.
- E. Rahimi, M. Bonyadian, M. Rafei, and H. R. Kazemeini, “Occurrence of aflatoxin M1 in raw milk of five dairy species in Ahvaz, Iran,” Food and Chemical Toxicology, vol. 48, no. 1, pp. 129–131, 2010.
- A. Heshmati and J. M. Milani, “Contamination of UHT milk by aflatoxin M1 in Iran,” Food Control, vol. 21, no. 1, pp. 19–22, 2010.
Copyright © 2012 Ali Mohamadi Sani et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.